DRUG DELIVERY CARRIER, AND COMPOSITION CONTAINING SAME
    4.
    发明公开
    DRUG DELIVERY CARRIER, AND COMPOSITION CONTAINING SAME 审中-公开
    药物递送载体,以及含有它的组合物

    公开(公告)号:EP3318282A1

    公开(公告)日:2018-05-09

    申请号:EP16818087.5

    申请日:2016-07-01

    Abstract: The present invention provides a carrier containing a first block copolymer and a second block copolymer, wherein the first block copolymer is a block copolymer of a first non-charged segment and a first complex-forming segment, at least some proportion of said first block copolymer is modified by a first molecule, the second block copolymer is a block copolymer of a second non-charged segment and a second complex-forming segment, and wherein at least some proportion of said second block copolymer is modified by a second molecule, said first molecule is a GLUT1 ligand, and said second molecule is different from the first molecule.

    Abstract translation: 本发明提供含有第一嵌段共聚物和第二嵌段共聚物的载体,其中第一嵌段共聚物是第一不带电荷的链段和第一配合物形成链段的嵌段共聚物,至少一部分所述第一嵌段共聚物 由第一分子改性,所述第二嵌段共聚物为第二不带电链段和第二配合物形成链段的嵌段共聚物,并且其中所述第二嵌段共聚物的至少一部分由第二分子改性,所述第一 分子是GLUT1配体,并且所述第二分子不同于第一分子。

    PROTEIN-POLYMER-DRUG CONJUGATES
    8.
    发明授权
    PROTEIN-POLYMER-DRUG CONJUGATES 有权
    蛋白质 - 聚合物 - WIRKSTOFFKONJUGATE

    公开(公告)号:EP2717916B1

    公开(公告)日:2017-03-08

    申请号:EP12728014.7

    申请日:2012-06-11

    Abstract: A drug conjugate is provided herein. The conjugate comprises a protein based recognition-molecule (PBRM) and a polymeric carrier comprising poly(1-hydroxymethylethylene hydroxymethyl-formal) (PHF) substituted with one or more -L D -D, the protein based recognition-molecule being connected to the polymeric carrier by L p . Each occurrence of D is independently a therapeutic agent having a molecular weight ‰¤ 5 kDa, L D and L p are linkers connecting the therapeutic agent and PBRM to the polymeric carrier respectively. Also disclosed are polymeric scaffolds comprising PHF useful for conjugating with a PBRM to form a polymer-drug-PBRM conjugate described herein, compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates of their compositions.

    Abstract translation: 本文提供药物缀合物。 缀合物包含基于蛋白质的识别分子(PBRM)和被一个或多个-LD-D取代的聚合物载体,基于蛋白质的识别分子通过LP连接到聚合物载体上。 每次发生的D独立地是具有分子量≦̸ 5kDa的治疗剂。 LD和LP分别是将治疗剂和PBRM分别连接到聚合物载体的接头。 还公开了可用于与PBRM缀合以形成本文所述的聚合物 - 药物-PBRM缀合物的聚合物支架,包含缀合物的组合物,其制备方法,以及用缀合物或其组合物治疗各种病症的方法。

    MULTI-ARM POLYETHYLENE GLYCOL-NITRINE DERIVATIVE
    10.
    发明公开
    MULTI-ARM POLYETHYLENE GLYCOL-NITRINE DERIVATIVE 审中-公开
    高分子聚乙二醇 - 硝基衍生物

    公开(公告)号:EP3078699A1

    公开(公告)日:2016-10-12

    申请号:EP14866860.1

    申请日:2014-12-02

    Abstract: Provided is a multi-arm polyethylene glycol-azido derivative of general formula I, wherein R is a central molecule, which is selected from a polyhydroxy structure, a polyamino structure or a polycarboxyl structure; n is the number of branches or arms, n≧3; PEG is the same or different -(CH 2 CH 2 O) m -, the average value of m being an integer from 3 to 250; X is a linking group of an azido end group; k is the number of the branches having the azido end group; F is selected from the group consisting of amino, carboxyl, sulfhydryl, ester group, maleic imide group and acrylic group; and Y is a linking group of an end group F.

    Abstract translation: 提供通式I的多臂聚乙二醇 - 叠氮基衍生物,其中R是选自多羟基结构,聚氨基结构或多羧基结构的中心分子; n是分支或武器的数量,n‰§3; PEG相同或不同 - (CH 2 CH 2 O)m - ,m的平均值为3至250的整数; X是叠氮基端基的连接基团; k是具有叠氮基端基的支链数; F选自氨基,羧基,巯基,酯基,马来酰亚胺基和丙烯酸基; Y是末端基团F的连接基团。

Patent Agency Ranking